Could Oral Paclitaxel Plus Encequidar Be Offered as Outpatient mBC Treatment?
April 5th 2021Gerardo Umanzor, MD, explains the potential benefits of oral paclitaxel and encequidar compared with the intravenous formulation for the treatment of metastatic breast cancer during the coronavirus disease 2019 pandemic.
Watch
Targeting PSMA in Advanced Prostate Cancer
March 30th 2021Experts in genitourinary oncology discuss emerging research surrounding the clinical utility of phenotypic biomarkers, such as prostate-specific membrane antigen (PSMA), for use in the treatment of metastatic castration-resistant prostate cancer.
Watch
A 72-Year-Old Man With Heavily Pretreated, Relapsed/Refractory Multiple Myeloma
March 30th 2021Sagar Lonial, MD, FACP, presents a case of a 72-year-old man with heavily pretreated relapsed/refractory multiple myeloma and discusses treatment options for patients with this diagnosis who have failed multiple prior lines of therapy.
Watch